Instruction for use: Vipsogal

ATX Code D07XC01 Betamethasone in combination with other drugs

Pharmacological group

Glucocorticosteroids

Nosological classification (ICD-10)

L40 Psoriasis

Chronic psoriasis with diffuse plaques, Generalized psoriasis, Psoriasis of the scalp, Psoriasis of the scalp, Generalized form of psoriasis, Psoriasis dermatitis, Psoriasis complicated by erythroderma, Invalidative psoriasis, Isolated psoriatic plaque, Exfoliative psoriasis, Psoriatic Erythroderma, Psoriasis with eczematosis, Hyperkeratosis in psoriasis,Inverse psoriasis,Psoriasis eczematous, Dermatosis of psoriasis, Psoriasis of the genitals, Psoriasis with lesions of hairy areas of skin, Erythrodermal psoriasis, Chronic psoriasis of the scalp, Chronic psoriasis, Ordinary psoriasis, Refractory psoriasis, Kebner phenomenon, Scaly lichen

Composition and form of release

100 grams of ointments contain betamethasone dipropionate 0.0175 g, fluocinonide 0.0175 g, gentamicin sulfate 35,000 IU (international unit), salicylic acid 5 g and panthenol 0.5 g; In tubes of 30 and 100 g.

pharmachologic effect

Pharmacological action - anti-inflammatory, antipruritic, keratolytic, antimicrobial.

Indications

Psoriasis, psoriasis dermatitis.

Contraindications

Hypersensitivity, tuberculosis, syphilitic, viral, fungal skin lesions, pregnancy, children's age (under 14 years).

Side effects

Teleangiectasia, atrophy and reduction of skin barrier functions, acne, photosensitivity.

Dosing and Administration

Locally, apply a thin layer on the affected areas 2 times a day and lightly rub. Duration of the course - no more than 21 days, repeated - in 2-3 weeks.

Precautionary measures

Avoid contact with ointment on mucous membranes and eyes. It is not recommended to use with an occlusive dressing and combine with preparations containing salicylic acid.

storage conditions

Keep out of the reach of children.

Shelf life

2 years.

Do not use after the expiry date printed on the package.